A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN)

Dirk Rades*, Carlos A Narvaez, Laura Splettstößer, Claudia Dömer, Cornelia Setter, Christian Idel, Julika Ribbat-Idel, Sven Perner, Tobias Bartscht, Denise Olbrich, Steven E Schild, Jesper Carl

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftArtikelForskningpeer review

Abstract

Mepitel� Film (MEP) and standard care (STD) were compared for radiation dermatitis in SCCHN patients. This trial was stopped prematurely since13/28 patients did not tolerate MEP. Grade ?2 dermatitis: 34.8% (MEP) vs. 35.7% (STD) at 50?Gy, 65.2% vs. 59.3% at 60?Gy. MEP was unsatisfactorily tolerated and appeared not superior (NCT03047174).

OriginalsprogEngelsk
Sider (fra-til)79-82
Antal sider4
TidsskriftRadiotherapy and Oncology
Vol/bind139
DOI
StatusUdgivet - okt. 2019

Bibliografisk note

Copyright � 2019 Elsevier B.V. All rights reserved.

Fingeraftryk

Udforsk hvilke forskningsemner 'A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN)' indeholder.

Citationsformater